Results 231 to 240 of about 16,904 (296)

Allergic Bronchopulmonary Aspergillosis (ABPA) in the Era of Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Modulators. [PDF]

J Fungi (Basel)
Chatterjee P, Moss CT, Omar S, Dhillon E, Hernandez Borges CD, Tang AC, Stevens DA, Hsu JL.   +7 more
europepmc   +1 more source

Overlap of Chronic Pulmonary Aspergillosis on Allergic Bronchopulmonary Aspergillosis. [PDF]

Intern Med
Ishiguro T, Isono T, Maruyama T, Ueda M, Shimizu Y, Takaku Y.   +5 more
europepmc   +1 more source

Long-Term Outcomes of Allergic Bronchopulmonary Aspergillosis and Aspergillus Colonization in Children and Adolescents with Cystic Fibrosis. [PDF]

J Fungi (Basel)
Chesshyre E, Warren FC, Shore AC, Davies JC, Armstrong-James D, Warris A.   +5 more
europepmc   +1 more source

Successful excision of an inflammatory endobronchial polyp using biopsy forceps with improvement in FEV1 in a patient with allergic bronchopulmonary aspergillosis: A case report

Fumihiro Kashizaki, Kenji Konishi, Chihiro Yamada, Shunsuke Okazaki, Hao Chen, Atsushi Miyasaka, Nanami Tsuchiya, Akitomo Kikuchi, Kentaro Yumoto, Yui Kojima, Hiroyuki Osawa, Harumi Koizumi, Ken­ichi Takahashi, Takeshi Kaneko   +13 more
openalex   +1 more source

Silicosis-Allergic Bronchopulmonary Aspergillosis Overlap-A Rare Duet!

Indian J Occup Environ Med
Neenu N, Utpat K, Desai U, Samuel M, Bagul R, Shah H.   +5 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Allergic bronchopulmonary aspergillosis in India

Clinical and Experimental Allergy, 2023
Allergic bronchopulmonary aspergillosis (ABPA) is a lung disorder caused by immune‐mediated reactions mounted against Aspergillus fumigatus. The disorder most commonly complicates the course of patients with asthma and cystic fibrosis.
R. Agarwal, I. Sehgal, V. Muthu, R. Dhar, D. Armstrong-James   +4 more
semanticscholar   +1 more source

Long‐term follow‐up of allergic bronchopulmonary aspergillosis treated with glucocorticoids: A study of 182 subjects

Mycoses (Berlin), 2023
The long‐term outcomes of allergic bronchopulmonary aspergillosis (ABPA) are poorly characterised.
R. Agarwal, I. Sehgal, V. Muthu, S. Dhooria, K. Prasad, A. Aggarwal, M. Garg, S. Rudramurthy, A. Chakrabarti   +8 more
semanticscholar   +1 more source

Clinical Manifestation and Treatment of Allergic Bronchopulmonary Aspergillosis

Seminars in Respiratory and Critical Care Medicine, 2023
Allergic bronchopulmonary aspergillosis (ABPA) is a complex hypersensitivity reaction to airway colonization by Aspergillus fumigatus in patients with asthma and cystic fibrosis. The pathophysiology of ABPA involves a complex interplay between the fungus
R. Agarwal, V. Muthu, I. Sehgal
semanticscholar   +1 more source

A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma

European Respiratory Journal, 2021
Background Whether a combination of glucocorticoid and antifungal triazole is superior to glucocorticoid alone in reducing exacerbations in patients with allergic bronchopulmonary aspergillosis (ABPA) remains unknown. We aimed to compare the efficacy and
R. Agarwal, V. Muthu, I. Sehgal, S. Dhooria, K. Prasad, M. Garg, A. Aggarwal, A. Chakrabarti   +7 more
semanticscholar   +1 more source